Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
A high priority research area for the Food and Drug Administration Center for Tobacco Products (FDA CTP) is determining who will start using tobacco products and who will stop using tobacco products. A population that has a disproportionately high amount of tobacco use are people living in rural areas. This indicates that some aspect of rurality is related to tobacco product susceptibility and decreased tobacco cessation rates. People in rural areas also typically have higher rates of alcohol use, which is also associated with higher tobacco use and decreased tobacco cessation rates. The purpose of this study is to (1) examine how rurality and alcohol use may affect susceptibility to existing and novel tobacco products and (2) examine how rurality and alcohol use may affect likelihood for tobacco users to substitute to tobacco cessation products. To accomplish this, the investigators will use behavioral economic measures to assess how people respond to novel tobacco products (high and low nicotine, flavored and unflavored), as well as use the experimental tobacco marketplace to determine how current users might switch to products associated with cessation. Because rurality is a spectrum, the investigators will be using an index of relative rurality (IRR) to better quantify how rurality and alcohol use affect these tobacco-related behaviors.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Cigarette/E-Cigarette Users
Inclusion Criteria:
Cigarette/E-Cigarette Non-Users
Inclusion Criteria:
Risky Alcohol Users
Inclusion Criteria:
Non-Risky Alcohol Users
Inclusion Criteria:
All groups
Inclusion Criteria:
Exclusion Critera:
Primary purpose
Allocation
Interventional model
Masking
737 participants in 2 patient groups
Loading...
Central trial contact
Mark J Rzeszutek, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal